<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05098015</url>
  </required_header>
  <id_info>
    <org_study_id>2021-N0155</org_study_id>
    <nct_id>NCT05098015</nct_id>
  </id_info>
  <brief_title>Randomized Controlled Trial of Game Changers</brief_title>
  <official_title>Controlled Trial of Game Changers: A Group Intervention to Train HIV Clients to be Change Agents for HIV Prevention in Uganda</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RAND</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Infectious Diseases Institute, Uganda</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Makerere University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>RAND</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a randomized controlled trial (RCT) of Game Changers, an 8-session peer-led&#xD;
      group intervention that aims to empower and mobilize people living with HIV (PLWH) to be&#xD;
      agents for HIV prevention in their social networks.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This RCT of Game Changers, a peer-led group intervention for persons living with HIV (PLWH)&#xD;
      in Uganda, will test intervention effects on the primary outcomes of reduced condomless sex,&#xD;
      increased HIV testing, and decreased enacted HIV stigma among social network members. We will&#xD;
      recruit 210 PLWH, randomizing 105 to the intervention and 105 to an attention control. Each&#xD;
      PLWH will be asked to recruit up to 4 social network members to complete assessments (736&#xD;
      total, 368/arm). All participants will complete surveys at baseline and 6-, 12-, and&#xD;
      18-months post-baseline.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 17, 2022</start_date>
  <completion_date type="Anticipated">August 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Individual randomization to one of two parallel groups, the intervention or usual care (no intervention) control group.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The assessment interviewer will be blinded to study arm allocation of the participants at baseline only.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>HIV testing</measure>
    <time_frame>Past 6 months</time_frame>
    <description>Self-reported HIV testing behavior by social network members (yes/no)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Condom use</measure>
    <time_frame>Past 6 months</time_frame>
    <description>Self-reported consistent condom use during intercourse by social network members (always vs sometime/never)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Internalized HIV stigma</measure>
    <time_frame>Past 6 months</time_frame>
    <description>Self-reported internalized HIV stigma among people living with HIV (on 1-5 scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HIV prevention advocacy</measure>
    <time_frame>Past 6 months</time_frame>
    <description>Self-reported prevention advocacy among people living with HIV (on 1-5 scale)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">573</enrollment>
  <condition>HIV Prevention</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8-session group intervention to train participants to engage in HIV prevention advocacy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will receive HIV usual care, and no added intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Game Changers</intervention_name>
    <description>8-session group intervention that uses didactic instruction, role plays and experience sharing to empower participants to engage in HIV prevention advocacy.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18 years and older&#xD;
&#xD;
          -  HIV-positive&#xD;
&#xD;
          -  in HIV care at The Infectious DIseases Institute for at least one year&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participated in the prior pilot study of the intervention.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Glenn Wagner</last_name>
    <role>Principal Investigator</role>
    <affiliation>RAND</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Glenn Wagner</last_name>
    <phone>310-393-0411</phone>
    <email>gwagner@rand.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laura Bogart</last_name>
    <phone>310-393-0411</phone>
    <email>lbogart@rand.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Infectious Diseases Institute</name>
      <address>
        <city>Kampala</city>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Violet Gwokyalya</last_name>
      <email>vgwokyalya@musph.ac.ug</email>
    </contact>
  </location>
  <location_countries>
    <country>Uganda</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 18, 2021</study_first_submitted>
  <study_first_submitted_qc>October 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2021</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>A de-identified dataset will be made available upon review of requests from outside researchers</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Following publication of primary results of the study (approximately August 2026).</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

